Finished Dosages
Laurus Labs seamlessly integrates its prowess in finished dosage form research and development with API back-integration at our state-of-the-art oral finished dosage facility in Visakhapatnam. This facility not only offers a comprehensive solution for our API clients but also elevates Laurus portfolio offerings on the pharmaceutical value chain.
With a robust installed capacity of 10 billion units for solid orals (capsules, tablets), our FDF business propels us toward our vision of becoming a leading global player in providing integrated pharmaceutical solutions.
With an installed of capacity of 10 billion units of solid orals (capsules, tablets), our FDF business moves us forward on our vision to become a leading player in offering integrated solutions to the global market.
Infrastructure
Capabilities
45
Sprawling campus covering three manufacturing blocks
10 billion
Installed manufacturing capacity for solid oral dosages
1,116+
personnel on-site, maintaining a manufacturing-to-quality ratio of 4:3
45
Audits by 20 regulatory authorities including USFDA, WHO, EMA, ANVISA, KFDA etc
Numerous client audits over the years, including collaborations with major pharmaceutical companies
Fully-serialized (Track & Trace) commercial supplies for enhanced traceability and accountability.
45
Sprawling campus covering three manufacturing blocks
10 billion
Installed manufacturing capacity for solid oral dosages
1,116+
personnel on-site, maintaining a manufacturing-to-quality ratio of 4:3
45
Audits by 20 regulatory authorities including USFDA, WHO, EMA, ANVISA, KFDA etc
Numerous client audits over the years, including collaborations with major pharmaceutical companies
Fully-serialized (Track & Trace) commercial supplies for enhanced traceability and accountability.
Technologies
Cutting-Edge Infrastructure for Unmatched Efficiency
Production Infrastructure
Wet granulators ranging from 125L to 2150L for precision in wet granulation processes. Bin Blender with capacities ranging from 75L to 1000L, facilitating efficient blending of materials.
READ MORE
Packaging and Inspection Infrastructure
Four Bottle packing lines with speeds ranging between 120 to 200 bottles per minute for streamlined packaging processes. Tablet inspection machines capable of examining 50,000 to 350,000 tablets per hour, ensuring product quality.
READ MORE
Top-of-the-Line Equipment
During equipment procurement, our commitment to excellence led us to select globally renowned brands, including Glatt, Bectochem, Bowman & Archer, ACG, Alexanderwerk, Fette, Kilian, O’Hara, IMA, Romaco, CVC, Aranow, and more.
READ MORE
Production Infrastructure
Wet granulators ranging from 125L to 2150L for precision in wet granulation processes. Bin Blender with capacities ranging from 75L to 1000L, facilitating efficient blending of materials.
READ MORE
Packaging and Inspection Infrastructure
Four Bottle packing lines with speeds ranging between 120 to 200 bottles per minute for streamlined packaging processes. Tablet inspection machines capable of examining 50,000 to 350,000 tablets per hour, ensuring product quality.
READ MORE
Top-of-the-Line Equipment
During equipment procurement, our commitment to excellence led us to select globally renowned brands, including Glatt, Bectochem, Bowman & Archer, ACG, Alexanderwerk, Fette, Kilian, O’Hara, IMA, Romaco, CVC, Aranow, and more.
READ MORE
Advanced Infrastructure for Orally Disintegrating Films (ODFs)
Complementary Capacity for ODF Manufacturing
In alignment with our proficiency in developing Orally Disintegrating Films (ODFs), our manufacturing facility boasts a state-of-the-art film-coating machine from iControl & HARRO HOFLIGER. This cutting-edge equipment is designed to enhance the manufacturing process of ODFs, ensuring precision and efficiency.
High-Speed Packing Capability
The facility is further equipped with a high-performance packing machine capable of efficiently packing 300 units per minute. This not only demonstrates our commitment to advanced technology but also highlights our emphasis on meeting high production demands without compromising on quality.
Complementary Capacity for ODF Manufacturing
In alignment with our proficiency in developing Orally Disintegrating Films (ODFs), our manufacturing facility boasts a state-of-the-art film-coating machine from iControl & HARRO HOFLIGER. This cutting-edge equipment is designed to enhance the manufacturing process of ODFs, ensuring precision and efficiency.
High-Speed Packing Capability
The facility is further equipped with a high-performance packing machine capable of efficiently packing 300 units per minute. This not only demonstrates our commitment to advanced technology but also highlights our emphasis on meeting high production demands without compromising on quality.
Cutting-Edge Tablet Inspection and Separation Technology
Technological Marvel - Enclony Automatic Inspection Machine
Laurus Labs upholds a stringent policy of inspecting every tablet and capsule for potential defects , regardless of the market or product. With our remarkable Enclony Automatic Inspection Machine, equipped with 36 cameras, we achieve this ambitious goal with exceptional efficiency. This technological marvel is capable of rapidly inspecting and sorting an impressive quantity of 350,000 tablets capsules per hour.
AI Application in Pharma Manufacturing
Adding a layer of sophistication, the Enclony machine can be trained to detect specific defects, showcasing the seamless integration of artificial intelligence (AI) in pharmaceutical manufacturing. This innovative approach ensures not only high-speed inspection but also a heightened level of precision in quality control processes.
Technological Marvel - Enclony Automatic Inspection Machine
Laurus Labs upholds a stringent policy of inspecting every tablet and capsule for potential defects , regardless of the market or product. With our remarkable Enclony Automatic Inspection Machine, equipped with 36 cameras, we achieve this ambitious goal with exceptional efficiency. This technological marvel is capable of rapidly inspecting and sorting an impressive quantity of 350,000 tablets capsules per hour.
AI Application in Pharma Manufacturing
Adding a layer of sophistication, the Enclony machine can be trained to detect specific defects, showcasing the seamless integration of artificial intelligence (AI) in pharmaceutical manufacturing. This innovative approach ensures not only high-speed inspection but also a heightened level of precision in quality control processes.
Solutions
Custom Manufacture Generic FDF
Laurus Labs adopts a Total Development approach, aligning with the strategies outlined in the R&D section. Upon confirming no conflict of interest with our own portfolio, our scope in this service covers formulation development and process optimization, analytical method development and validation, technology-document preparation, transfer to plant, plant-scale process validation by R&D, regulatory filing, and ultimately, commercial-scale manufacture and supply.
Custom Manufacture Proprietary FDF, Intermediates
Following the total development approach detailed in the R&D section, Laurus Labs offers an extensive solution encompassing formulation development, process optimization, analytical method development and validation, technology-document preparation, transfer to plant, plant-scale process validation by R&D, regulatory filing (CMC) support for filing of DMF by the client, and concluding with commercial-scale manufacture and supply.
Contract Manufacture Tech-transfer projects
Utilizing the provided dossier of the transferred-in process, Laurus Labs takes full responsibility in this offering, covering all aspects of manufacturing, obtaining necessary raw materials, adhering to Good Manufacturing Practices (GMP), ensuring the quality of the finished product, and ultimately ensuring effective delivery.
Clinical-scale Manufacturing
Whether utilizing a client-provided formula or developing the formulation and analytical development from scratch, Laurus Labs is equipped to manufacture large-volume clinical supplies for certain solid oral drug products. Our expertise spans from toxicological evaluation to Phase-III clinical trials, ensuring a comprehensive clinical drug substance manufacturing solution.
Products
Please visit our subsidiary sites below for a complete list of products:
Related Case Studies
